Mice with tumors orthotopically-implanted in the mouse cecum were injected with DyLight 650-conjugated anti-IGF-1R (clone 24–31) antibody with a single 30 μg dose via the tail vein 14 days after tumor implantation. This evidence concerns the gene IGF1R and neoplasm.